Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

October 18, 2000 8:30-8:45. Problem Solving with FDG Positron Emission Mammography.

Adler1, Freimanis, Lesko

  • 1Wake Forest University, Winston-Salem, NC, USA

Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T
|January 11, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Coarsening of a class of driven striped structures

Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics·2001
Same author

Endogenous interleukin 6 production protects against histopathologic damage in a murine model of ischemia/reperfusion injury.

Current surgery·2000
Same author

Influence of environmental conditions on the activity of the recombinant mannuronan C-5-epimerase AlgE2.

Enzyme and microbial technology·2000
Same author

Gene network dynamics and the evolution of development.

Trends in ecology & evolution·2000
Same author

Measurement of direct photon emission in K+-->pi(+)pi(0)gamma decay

Physical review letters·2000
Same author

Ischemic Stroke Prevention.

Current treatment options in neurology·2000
Same journal

Changes in FDG Tumor Uptake during and after Fractionated Radiation Therapy in a Rodent Tumor Xenograft.

Clinical positron imaging : official journal of the Institute for Clinical P.E.T·2003
Same journal

Diabetes Decreases FDG Accumulation in Primary Lung Cancer.

Clinical positron imaging : official journal of the Institute for Clinical P.E.T·2003
Same journal

Relationship between Gastrointestinal F-18-fluorodeoxyglucose Accumulation and Gastrointestinal Symptoms in Whole-Body PET.

Clinical positron imaging : official journal of the Institute for Clinical P.E.T·2003
Same journal

Utility of PET in Breast Cancer.

Clinical positron imaging : official journal of the Institute for Clinical P.E.T·2003
Same journal

FDG-PET in Esophageal Cancer. Incremental Value over Computed Tomography.

Clinical positron imaging : official journal of the Institute for Clinical P.E.T·2003
Same journal

Electronic Generators for the Production of Positron-Emitter Labeled Radiopharmaceuticals. Where Would PET Be Without Them?

Clinical positron imaging : official journal of the Institute for Clinical P.E.T·2003
See all related articles

Dedicated positron emission mammography devices show promise for detecting breast cancers missed by mammograms. This technology can identify suspicious lesions with low mammogram suspicion, aiding early diagnosis.

Area of Science:

  • Medical Imaging
  • Oncology
  • Nuclear Medicine

Background:

  • Dedicated breast imaging devices utilize fluorodeoxyglucose (FDG) with technical specifications suitable for small breast cancer detection.
  • Features include x-ray registration, high count sensitivity, and 2-3 mm spatial resolution.

Purpose of the Study:

  • To investigate a potential clinical use of dedicated positron emission mammography devices.
  • To evaluate the efficacy of these devices in identifying breast cancers that may be subtle or missed on conventional mammography.

Main Methods:

  • Prospective IRB-approved clinical trials involving patients scheduled for biopsy.
  • Patients received intravenous FDG injection prior to biopsy or lumpectomy.
  • Positron emission mammograms were performed using a dedicated device and compared with histopathology.

Related Experiment Videos

Main Results:

  • Identified three patients with mammographically occult or subtly abnormal findings.
  • Positron emission mammograms revealed suspicious hypermetabolic activity (hot spots) in these cases.
  • Subsequent histopathology confirmed cancer in all three patients.

Conclusions:

  • Dedicated positron emission mammography devices may aid in detecting mammographically occult or low-suspicion breast cancers.
  • The role of these devices is evolving, with potential for improving early cancer detection.
  • Further research is necessary to fully define the capabilities and limitations of this imaging technique.